PAVmed reports Q4 2025 results, strengthens capital structure
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/20/2026
- Wall St set to open higher as chips recover, megacap earnings loom
- Oil steadies as hopes of renewed US-Iran negotiations offset Houthi threat
- Selloff of U.S. memory stocks creates a compelling entry point: analyst
- Why Moonshot AI's Kimi K3 is actually bullish for memory stocks
- AMC Entertainment soars on record quarterly results
- Cantor Fitzgerald Starts Trulieve Cannabis (TRLV) at Overweight, 'Purpose-Built for a New Cannabis Regulatory Framework'
- Wall St set to open higher as chips recover, megacap earnings loom
- IREN raises 2026 revenue target to $4bn after $2.8bn in contracts
- Oil steadies as hopes of renewed US-Iran negotiations offset Houthi threat
- AMC Entertainment (AMC) Tops Q2 EPS by 16c
PAVmed Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results
March 30, 2026 8:01 AM EDTPAVmed strengthened its capital structure and relaunched its medical device portfolio under new leadership
Veris Health advanced strategic partnership with OSU and progressed implantable physiological monitor toward FDA submission
Lucid Diagnostics expanded EsoGuard healthcare system access and clinical evidence base
Conference call and webcast to be held today, March 30, at 8:30 AM... More
